Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Impact of expanded influenza post-exposure prophylaxis on healthcare worker absenteeism at a tertiary care center during the 2017-2018 season.

Puig-Asensio M, Douglas M, Holley S, Kukla ME, Abosi O, Mascardo L, Carmody B, Gent C, Diekema DJ, Hartley P, Edmond MB, Salinas JL.

Infect Control Hosp Epidemiol. 2019 Feb;40(2):260-261. doi: 10.1017/ice.2018.317. Epub 2018 Dec 7. No abstract available.

PMID:
30522537
2.

Comparing brief, covert, directly observed hand hygiene compliance monitoring to standard methods: A multicenter cohort study.

Werzen A, Thom KA, Robinson GL, Li S, Rock C, Herwaldt LA, Diekema DJ, Reisinger HS, Perencevich EN.

Am J Infect Control. 2018 Oct 9. pii: S0196-6553(18)30864-2. doi: 10.1016/j.ajic.2018.08.015. [Epub ahead of print]

PMID:
30314747
3.

Point-Counterpoint: Active Surveillance for Carriers of Toxigenic Clostridium difficile Should Be Performed To Guide Prevention Efforts.

McDonald LC, Diekema DJ.

J Clin Microbiol. 2018 Jul 26;56(8). pii: e00782-18. doi: 10.1128/JCM.00782-18. Print 2018 Aug.

4.

Impact of 2018 Changes in National Healthcare Safety Network Surveillance for Clostridium difficile Laboratory-Identified Event Reporting.

Marra AR, Edmond MB, Ford BA, Herwaldt LA, Algwizani AR, Diekema DJ.

Infect Control Hosp Epidemiol. 2018 Jul;39(7):886-888. doi: 10.1017/ice.2018.86. Epub 2018 Apr 30. No abstract available.

PMID:
29708091
5.

Comparing and optimizing ultraviolet germicidal irradiation systems use for patient room terminal disinfection: an exploratory study using radiometry and commercial test cards.

Masse V, Hartley MJ, Edmond MB, Diekema DJ.

Antimicrob Resist Infect Control. 2018 Feb 22;7:29. doi: 10.1186/s13756-018-0317-1. eCollection 2018.

6.

Bioaerosol concentrations generated from toilet flushing in a hospital-based patient care setting.

Knowlton SD, Boles CL, Perencevich EN, Diekema DJ, Nonnenmann MW; CDC Epicenters Program.

Antimicrob Resist Infect Control. 2018 Jan 26;7:16. doi: 10.1186/s13756-018-0301-9. eCollection 2018.

7.

Research Agenda for Microbiome Based Research for Multidrug-resistant Organism Prevention in the Veterans Health Administration System.

Kates AE, Tischendorf JS, Schweizer M, Herwaldt L, Samore M, Dukes KC, Gerding DN, Diekema DJ, Safdar N.

Infect Control Hosp Epidemiol. 2018 Feb;39(2):202-209. doi: 10.1017/ice.2017.311. No abstract available.

PMID:
29417924
8.

Draft Genome Sequence of USA100 Methicillin-Resistant Staphylococcus aureus Strain 209.

Chen Y, Crosby HA, Oosthuysen WF 2nd, Diekema DJ, Kelley ST, Horswill AR.

Genome Announc. 2018 Jan 4;6(1). pii: e01399-17. doi: 10.1128/genomeA.01399-17.

9.

Discontinuing contact precautions for multidrug-resistant organisms: A systematic literature review and meta-analysis.

Marra AR, Edmond MB, Schweizer ML, Ryan GW, Diekema DJ.

Am J Infect Control. 2018 Mar;46(3):333-340. doi: 10.1016/j.ajic.2017.08.031. Epub 2017 Oct 12.

PMID:
29031432
10.

Infection prevention strategies for procedures performed outside operating rooms: A conceptual integrated model.

Masse V, Edmond MB, Diekema DJ.

Am J Infect Control. 2018 Jan;46(1):94-96. doi: 10.1016/j.ajic.2017.07.030. Epub 2017 Sep 21.

PMID:
28941559
11.

Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014.

Goto M, Schweizer ML, Vaughan-Sarrazin MS, Perencevich EN, Livorsi DJ, Diekema DJ, Richardson KK, Beck BF, Alexander B, Ohl ME.

JAMA Intern Med. 2017 Oct 1;177(10):1489-1497. doi: 10.1001/jamainternmed.2017.3958. Erratum in: JAMA Intern Med. 2017 Oct 1;177(10):1544.

12.

Diagnostic Stewardship-Leveraging the Laboratory to Improve Antimicrobial Use.

Morgan DJ, Malani P, Diekema DJ.

JAMA. 2017 Aug 15;318(7):607-608. doi: 10.1001/jama.2017.8531. No abstract available.

PMID:
28759678
13.

Mycobacterium chimaera Infections Associated With Contaminated Heater-Cooler Devices for Cardiac Surgery: Outbreak Management.

Marra AR, Diekema DJ, Edmond MB.

Clin Infect Dis. 2017 Aug 15;65(4):669-674. doi: 10.1093/cid/cix368. Review.

PMID:
28430899
14.

Rising Stakes for Health Care-Associated Infection Prevention: Implications for the Clinical Microbiology Laboratory.

Diekema DJ.

J Clin Microbiol. 2017 Apr;55(4):996-1001. doi: 10.1128/JCM.02544-16. Epub 2017 Jan 25.

15.

Investigation of a Candida guilliermondii Pseudo-outbreak Reveals a Novel Source of Laboratory Contamination.

Kirby JE, Branch-Elliman W, LaSalvia MT, Longhi L, MacKechnie M, Urman G, Baldini LM, Muriel FR, Sullivan B, Yassa DS, Gold HS, Wagner TK, Diekema DJ, Wright SB.

J Clin Microbiol. 2017 Apr;55(4):1080-1089. doi: 10.1128/JCM.02336-16. Epub 2017 Jan 18.

16.

Mycobacterium chimaera Outbreak Associated With Heater-Cooler Devices: Piecing the Puzzle Together.

Sommerstein R, Schreiber PW, Diekema DJ, Edmond MB, Hasse B, Marschall J, Sax H.

Infect Control Hosp Epidemiol. 2017 Jan;38(1):103-108. doi: 10.1017/ice.2016.283. Epub 2016 Nov 14. Review.

PMID:
27839530
17.

Failure of Risk-Adjustment by Test Method for C. difficile Laboratory-Identified Event Reporting.

Marra AR, Edmond MB, Ford BA, Herwaldt LA, Algwizani AR, Diekema DJ.

Infect Control Hosp Epidemiol. 2017 Jan;38(1):109-111. doi: 10.1017/ice.2016.227. Epub 2016 Oct 17.

PMID:
27745553
18.

Increased Mortality Rates Associated with Staphylococcus aureus and Influenza Co-infection, Maryland and Iowa, USA(1).

McDanel JS, Perencevich EN, Storm J, Diekema DJ, Herwaldt L, Johnson JK, Winokur PL, Schweizer ML.

Emerg Infect Dis. 2016 Jul;22(7):1253-6. doi: 10.3201/eid2207.151319.

19.

Detection and Prevalence of Penicillin-Susceptible Staphylococcus aureus in the United States in 2013.

Richter SS, Doern GV, Heilmann KP, Miner S, Tendolkar S, Riahi F, Diekema DJ.

J Clin Microbiol. 2016 Mar;54(3):812-4. doi: 10.1128/JCM.03109-15. Epub 2016 Jan 13.

20.

Association between microbial characteristics and poor outcomes among patients with methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study.

McDanel JS, Perencevich EN, Diekema DJ, Winokur PL, Johnson JK, Herwaldt LA, Smith TC, Chrischilles EA, Dawson JD, Schweizer ML.

Antimicrob Resist Infect Control. 2015 Dec 14;4:51. doi: 10.1186/s13756-015-0092-1. eCollection 2015.

21.

Novel Staphylococcus aureus Secreted Protein Alters Keratinocyte Proliferation and Elicits a Proinflammatory Response In Vitro and In Vivo.

Merriman JA, Klingelhutz AJ, Diekema DJ, Leung DY, Schlievert PM.

Biochemistry. 2015 Aug 11;54(31):4855-62. doi: 10.1021/acs.biochem.5b00523. Epub 2015 Jul 28.

22.

Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery.

Schweizer ML, Chiang HY, Septimus E, Moody J, Braun B, Hafner J, Ward MA, Hickok J, Perencevich EN, Diekema DJ, Richards CL, Cavanaugh JE, Perlin JB, Herwaldt LA.

JAMA. 2015 Jun 2;313(21):2162-71. doi: 10.1001/jama.2015.5387.

PMID:
26034956
23.

Lessons learned from hospital Ebola preparation.

Morgan DJ, Braun B, Milstone AM, Anderson D, Lautenbach E, Safdar N, Drees M, Meddings J, Linkin DR, Croft LD, Pineles L, Diekema DJ, Harris AD.

Infect Control Hosp Epidemiol. 2015 Jun;36(6):627-31. doi: 10.1017/ice.2015.61.

PMID:
25994323
24.

Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.

McDanel JS, Perencevich EN, Diekema DJ, Herwaldt LA, Smith TC, Chrischilles EA, Dawson JD, Jiang L, Goto M, Schweizer ML.

Clin Infect Dis. 2015 Aug 1;61(3):361-7. doi: 10.1093/cid/civ308. Epub 2015 Apr 21.

PMID:
25900170
25.

Contact precautions for patients with multidrug-resistant pathogens--reply.

Morgan DJ, Kaye KS, Diekema DJ.

JAMA. 2015 Feb 10;313(6):630. doi: 10.1001/jama.2014.17448. No abstract available.

PMID:
25668276
26.

Multilaboratory testing of antifungal drug combinations against Candida species and Aspergillus fumigatus: utility of 100 percent inhibition as the endpoint.

Ren P, Luo M, Lin S, Ghannoum MA, Isham N, Diekema DJ, Pfaller MA, Messer S, Lockhart SR, Iqbal N, Chaturvedi V.

Antimicrob Agents Chemother. 2015 Mar;59(3):1759-66. doi: 10.1128/AAC.04545-14. Epub 2014 Dec 15.

27.

Ebola virus disease and the need for new personal protective equipment.

Edmond MB, Diekema DJ, Perencevich EN.

JAMA. 2014 Dec 17;312(23):2495-6. doi: 10.1001/jama.2014.15497. No abstract available.

PMID:
25350321
28.

Reconsidering isolation precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.

Morgan DJ, Kaye KS, Diekema DJ.

JAMA. 2014 Oct 8;312(14):1395-6. doi: 10.1001/jama.2014.10142. No abstract available.

PMID:
25291571
29.

Ebola fever: reconciling planning with risk in U.S. hospitals.

Klompas M, Diekema DJ, Fishman NO, Yokoe DS.

Ann Intern Med. 2014 Nov 18;161(10):751-2. doi: 10.7326/M14-1918. No abstract available.

PMID:
25141883
30.

Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.

Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Doern GV.

Antimicrob Agents Chemother. 2014 Nov;58(11):6484-9. doi: 10.1128/AAC.03344-14. Epub 2014 Aug 18.

31.

Methicillin-resistant Staphylococcus aureus prevention practices in hospitals throughout a rural state.

McDanel JS, Ward MA, Leder L, Schweizer ML, Dawson JD, Diekema DJ, Smith TC, Chrischilles EA, Perencevich EN, Herwaldt LA.

Am J Infect Control. 2014 Aug;42(8):868-73. doi: 10.1016/j.ajic.2014.05.004.

PMID:
25087139
32.

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.

Pfaller MA, Andes DR, Diekema DJ, Horn DL, Reboli AC, Rotstein C, Franks B, Azie NE.

PLoS One. 2014 Jul 3;9(7):e101510. doi: 10.1371/journal.pone.0101510. eCollection 2014.

33.

Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers.

Vu BG, Stach CS, Salgado-Pabón W, Diekema DJ, Gardner SE, Schlievert PM.

J Infect Dis. 2014 Dec 15;210(12):1920-7. doi: 10.1093/infdis/jiu350. Epub 2014 Jun 20.

34.

Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and interpretive criteria.

Pfaller MA, Diekema DJ, Jones RN, Castanheira M.

J Clin Microbiol. 2014 Sep;52(9):3223-9. doi: 10.1128/JCM.00782-14. Epub 2014 Jun 20.

35.

Reply to Burden et al.

Diekema DJ.

Infect Control Hosp Epidemiol. 2014 Jun;35(6):744. doi: 10.1086/676444. No abstract available.

PMID:
24799659
36.

Multicenter evaluation of the new Vitek 2 yeast susceptibility test using new CLSI clinical breakpoints for fluconazole.

Pfaller MA, Diekema DJ, Procop GW, Wiederhold NP.

J Clin Microbiol. 2014 Jun;52(6):2126-30. doi: 10.1128/JCM.00658-14. Epub 2014 Apr 9.

37.

Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis.

Feazel LM, Malhotra A, Perencevich EN, Kaboli P, Diekema DJ, Schweizer ML.

J Antimicrob Chemother. 2014 Jul;69(7):1748-54. doi: 10.1093/jac/dku046. Epub 2014 Mar 14. Review.

PMID:
24633207
38.

Antibacterial properties of the CFTR potentiator ivacaftor.

Reznikov LR, Abou Alaiwa MH, Dohrn CL, Gansemer ND, Diekema DJ, Stoltz DA, Welsh MJ.

J Cyst Fibros. 2014 Sep;13(5):515-9. doi: 10.1016/j.jcf.2014.02.004. Epub 2014 Mar 5.

39.

Concordance of nasal and diabetic foot ulcer staphylococcal colonization.

Haleem A, Schultz JS, Heilmann KP, Dohrn CL, Diekema DJ, Gardner SE.

Diagn Microbiol Infect Dis. 2014 May;79(1):85-9. doi: 10.1016/j.diagmicrobio.2014.01.014. Epub 2014 Jan 24.

40.

Continued emergence of USA300 methicillin-resistant Staphylococcus aureus in the United States: results from a nationwide surveillance study.

Diekema DJ, Richter SS, Heilmann KP, Dohrn CL, Riahi F, Tendolkar S, McDanel JS, Doern GV.

Infect Control Hosp Epidemiol. 2014 Mar;35(3):285-92. doi: 10.1086/675283. Epub 2014 Jan 29.

PMID:
24521595
41.

Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method.

Pfaller MA, Espinel-Ingroff A, Bustamante B, Canton E, Diekema DJ, Fothergill A, Fuller J, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SR, Martin-Mazuelos E, Meis JF, Ostrosky-Zeichner L, Pelaez T, St-Germain G, Turnidge J.

Antimicrob Agents Chemother. 2014;58(2):916-22. doi: 10.1128/AAC.02020-13. Epub 2013 Nov 25.

42.

Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States.

Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Crispell EK, Riahi F, McDanel JS, Satola SW, Doern GV.

Antimicrob Agents Chemother. 2014;58(2):740-5. doi: 10.1128/AAC.01915-13. Epub 2013 Nov 18.

43.

Public reporting of health care-associated surveillance data: recommendations from the healthcare infection control practices advisory committee.

Talbot TR, Bratzler DW, Carrico RM, Diekema DJ, Hayden MK, Huang SS, Yokoe DS, Fishman NO; Healthcare Infection Control Practices Advisory Committee.

Ann Intern Med. 2013 Nov 5;159(9):631-5. doi: 10.7326/0003-4819-159-9-201311050-00011.

44.

Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria.

Pfaller MA, Messer SA, Diekema DJ, Jones RN, Castanheira M.

J Clin Microbiol. 2014 Jan;52(1):108-14. doi: 10.1128/JCM.02481-13. Epub 2013 Oct 23.

45.

Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates.

Castanheira M, Woosley LN, Messer SA, Diekema DJ, Jones RN, Pfaller MA.

Antimicrob Agents Chemother. 2014;58(1):577-80. doi: 10.1128/AAC.01674-13. Epub 2013 Oct 14.

46.

Survey of high school athletic programs in Iowa regarding infections and infection prevention policies and practices.

Pedersen M, Doyle MR, Beste A, Diekema DJ, Zimmerman MB, Herwaldt LA.

Iowa Orthop J. 2013;33:107-13.

47.

Evaluation of pneumococcal serotyping by multiplex PCR and quellung reactions.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV.

J Clin Microbiol. 2013 Dec;51(12):4193-5. doi: 10.1128/JCM.01876-13. Epub 2013 Sep 11.

48.

Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.

Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG.

Diagn Microbiol Infect Dis. 2013 Sep;77(1):37-40. doi: 10.1016/j.diagmicrobio.2013.05.019. Epub 2013 Jul 16.

PMID:
23870164
49.

Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV.

Emerg Infect Dis. 2013 Jul;19(7):1074-83. doi: 10.3201/eid1907.121830.

50.

Rapid detection of antibiotic-resistant organism carriage for infection prevention.

Diekema DJ, Pfaller MA.

Clin Infect Dis. 2013 Jun;56(11):1614-20. doi: 10.1093/cid/cit038. Epub 2013 Jan 29. Review.

PMID:
23362298

Supplemental Content

Loading ...
Support Center